pSivida signs contract with Cirrus Pharma

Sep. 6, 2005 – Nanotechnology company pSivida Limited (NASDAQ:PSDV) announced it signed a contract with Cirrus Pharmaceuticals Inc. to accelerate and expand development of a number of specific drug candidates formulated in its BioSilicon material.

The company says the development contract will have an initial extendable term of one year and provide a dedicated team of scientists from Cirrus. The relationship has been established to generate new products based on reformulating existing specific generic and proprietary drugs and their delivery utilizing BioSilicon.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.